Dublin’s pain relief history helps it gain congress

Ireland’s history in pain management and its hub of pharmaceutical companies has helped Dublin win the bid to host the 12th European Pain Federation Congress (EFIC) in 2021.

The congress is expected to bring some 3,000 multidisciplinary clinicians and researchers from the fields of pain science to the city, contributing over €4 million to the local economy.

Ireland has a long history in pain management research with the first subcutaneous injection administered for pain relief invented by Dublin doctor, Dr Rynd in 1844.

Ireland’s Life Sciences sector has grown to reach global significance, with collaborative clusters in Pharmaceutical, Biotechnology, Medical Devices and Diagnostics.

Joanne O’Brien, President of the Irish Pain Society (IPS), presented the successful bid, along with letters of support from both the former Lord Mayor of Dublin Nial Ring and Minister for Health, Simon Harris, to EFIC’s Executive Board in Brussels.

O’Brien said: “The Irish Pain Society is honoured to welcome the 12th EFIC to the vibrant city of Dublin, home of Dr Francis Rynd, inventor of the first hypodermic needle, a game changer in modern pain management. We are delighted that our own University College Dublin Associate Professor Brona Fullen will be President of EFIC at this time, and together with the Scientific Chair, Prof Eija Kalso, will bring together the world’s leading experts to exchange knowledge, ideas and the latest advances in the field of pain science.”

The bid was supported by Dublin Convention Bureau (DCB), Fáilte Ireland and host venue the Convention Centre Dublin (CCD).

Adrienne Clarke, Head of Conference Sales at the CCD added: “We are looking forward to welcoming EFIC to Dublin after working closely with IPS, DCB and Fáilte Ireland. With more than 75 pharmaceutical companies operating in Ireland, including the top 10 in the world, Dublin is a great fit for this type of congress.”


(Via Irish Medical Times, IDA Ireland)